Enhancement of contextual fear-conditioning by putative (±)-α-amino- 3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor modulators and N-methyl-D-aspartate (NMDA) receptor antagonists in DBA/2J mice

Brain Research

Volumn 768, Issue 1-2, 1997, Pages 197-207

  Lu, Ying ^a   Wehner, Jeanne M ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

AMPA antagonist; Aniracetam; C57 mouse; Contextual fear conditioning; DBA mouse; NMDA antagonist; Oxiracetam

Indexed keywords

1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 3 AMINO 1 HYDROXY 2 PYRROLIDINONE; 4 (3 PHOSPHONOPROPYL) 2 PIPERAZINECARBOXYLIC ACID; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR; ANIRACETAM; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; OXIRACETAM;

ANIMAL EXPERIMENT; ARTICLE; CONDITIONING; CONTROLLED STUDY; DOSE RESPONSE; FEAR; LEARNING DISORDER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TASK PERFORMANCE;

ACOUSTIC STIMULATION; ANIMALS; ANTI-ANXIETY AGENTS; BENZODIAZEPINES; CONDITIONING, CLASSICAL; CUES; EXCITATORY AMINO ACID ANTAGONISTS; FEAR; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; NOOTROPIC AGENTS; PYRROLIDINES; PYRROLIDINONES; QUINOXALINES; RECEPTORS, AMPA; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0030879790     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00644-6     Document Type: Article

References (58)

1. Ammassari-Teule M., Caprioli A. Spatial learning and memory, maze running strategies and cholinergic mechanisms in two inbred strains of mice. Behav. Brain Res. 17:1985;9-16.
2. Bagetta G., Nistico G., Bowery N.G. Prevention by the NMDA receptor antagonist, MK801, of neuronal loss produced by tetanus toxin in the rat hippocampus. Br. J. Pharmcol. 101:1990;776-780.
3. Z.I. Bashir, N. Berretta, Z.A. Bortolotto, K. Clark, C.H. Davies, B.G. Frenguelli, J. Harvey, B. Potier, G.L. Collingridge, NMDA receptors and long-term potentiation in the hippocampus, in: G.L. Collingridge, J.C. Watkins (Eds.), The NMDA Receptor, Oxford University Press, 1994, pp. 294-312.
4. Belfiore P., Ponzio F., Biagetti R., Berettera C., Magnani M., Pozzi O. Oxiraxetam prevents the hippocampal cholinergic hypofunction induced by the NMDA receptor blocker AP7. Neurosci. Lett. 143:1992;127-130.
5. Bonta I.L., De Vos C.J., Grijsen H., Hillen F.C., Noach E.L., Sim A.W. 1-Hydroxy-3-amino-pyrrolidone-2 (HA-966): a new GABA-like compound, with potential use in extrapyramidal diseases. Br. J. Pharmacol. 43:1971;514-535.
6. Bowers B.J., Christensen S.C., Pauley J.R., Paylor R., Yuva L., Dunbar S.E., Wehner J.M. Protein and molecular characterization of hippocampal protein kinase C in C57BL/6 and DBA/2 mice. J. Neurochem. 64:1995;2737-2746.
7. Coan E.J., Irving A.J., Collingride G.L. Low-frequency activation of the NMDA receptor system can prevent the induction of LTP. Neurosci. Lett. 105:1989;205-210.
8. Collingridge G.L., Kehl S.J., Mclennan H. Excitatory amino acids in synaptic transmission in the Schaffer-collateral commissural pathway of the rat hippocampus. J. Physiol. 334:1983;33-46.
9. Copani A., Genazzani A.A., Aleppo G., Casabona G., Canonico P.L., Scapagnini U., Nicoletti F. Nootropic drugs positively modulate α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-sensitive glutamate receptors in neuronal cultures. J. Neurochem. 58:1992;1199-1204.
10. Crusio W.E., Schwegler H., Lipp H.P. Radial-maze performance and structural variation of the hippocampus in mice: a correlation with mossy fibre distribution. Brain Res. 425:1987;182-185.
11. Crusio W.E., Schwegier H., van Abeelen J.H.F. Behavioral responses of novelty and structural variation of the hippocampus in mice. II. Multivariate genetic analysis. Behav. Brain Res. 32:1989;81-88.
12. Cumin R., Bandle E.F., Gamzu E., Haefely W.E. Effects of the novel compound aniracetam upon impaired learning and memory in rodents. Psychopharmacology. 78:1982;104-111.
13. Davies S.N., Lester R.A., Reymann K.G., Collingridge G.L. Temporally distinct pre- and post-synaptic mechanisms maintain long-term potentiation. Nature. 338:1989;500-503.
14. Fordyce D.E., Clark V.J., Paylor R., Wehner J.M. Enhancement of hippocampally- mediated learning and protein kinase C activity by oxiracetam in learning-impaired DBA/2 mice. Brain Res. 672:1995;170-176.
15. Fordyce D.E., Bhat R.V., Baraban J.M., Wehner J.M. Genetic and activity-dependent regulation of Zif268 expression: association with spatial learning. Hippocampus. 4:1994;559-568.
16. Foster A.C., Gill R., Woodruff G.N. Neuroprotective effects of MK-801 in vivo: selectivity and evidence for delayed degeneration mediated by NMDA receptor activation. J. Neurosci. 8:1988;4745-4754.
17. Huang Y.-Y., Colino A., Selig D.K., Malenka R.C. The influence of prior synaptic activity on the induction of long-term potentiation. Science. 255:1992;730-733.
18. Isaac J.T.R., Nicoll R.A., Malenka R.C. Evidence for silent synapses: implications for the expression of LTP. Neuron. 15:1995;427-434.
19. Isaacson J.S., Nicoll R.A. Aniracetam reduces glutamate receptor desensitization and slows the decay of fast excitatory synaptic currents in the hippocampus. Proc. Natl. Acad. Sci. USA. 88:1991;10936-10940.
20. Ito B.I., Tanabe S., Kohda A., Sugiyama H. Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam. J. Physiol. 424:1990;533-545.
21. Kim J.J., Fanselow M.S. Modality-specific retrograde amnesia of fear. Science. 256:1992;675-677.
22. A. Kubota, T. Hayashi, T. Sakagami, A. Watanabe, K. Nakamura, Scopolamine model of retrograde amnesia: its prevention and relevant cerebral nuclei involved, in: S. Saito, T. Yanagita (Eds.), Learning and Memory, Excerpta Medica, Amsterdam, 1983, pp. 96-118.
23. Lehmann J., Schneider J., McPherson S., Murphy D.E., Bernard P., Tsai C., Bennett D.A., Pastor G., Steel D.J., Boehm C., Cheney D.L., Liebman J.M., Williams M., Wood P.L. CPP, a selective N-methyl-D-Aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo. J. Pharmacol. Exp. Ther. 240:1987;737-746.
24. Liao D., Hessler N.A., Malinow R. Activation of postsynaptically silent synapses during pairing-induced LTP in CA1 region of hippocampal slice. Nature. 375:1995;400-404.
25. S.F. Logue, R. Paylor, J.M. Wehner, Hippocampal lesions cause learning deficits in inbred mice in Morris water maze and conditioned fear tasks, Behav. Neurosci. 111 (1997) 104-113.
26. Lucchi L., Pascale A., Battaini F., Govoni S., Trabucchi M. Cognition stimulating drugs modulate protein kinase C activity in cerebral cortex and hippocampus of adult rats. Life Sci. 53:1993;1821-1832.
27. Malenfant S.A., O'Hearn S., Fleming A.S. MK801, an NMDA antagonist, blocks acquisition of a spatial task but does not block maternal experience effects. Physiol. Behav. 49:1991;1129-1137.
28. Malenka R.C., Nicoll R.A. NMDA-receptor-dependent synaptic plasticity: multiple forms and mechanisms. Trends Neurosci. 16:1993;521-526.
29. Malinow R. LTP: Desperately seeking resolution. Science. 266:1994;1195-1196.
30. Maren S., Tocco G., Standley S., Baudry M., Thompson R.F. Postsynaptic factors in the expression of long-term potentiation (LTP): increased glutamate receptor binding following LTP induction in vivo. Proc. Natl. Acad. Sci. USA. 90:1993;9654-9658.
31. Ohno M., Yamamoto T., Watanabe S. Effects of intrahippocampal injections of N-methyl-D-aspartate receptor antagonists and scopolamine on working and reference memory assessed in rats by a three-panel runway task. J. Pharmacol. Exp. Ther. 263:1992;943-950.
32. Parada J., Czuczwar S.J., Turski W.A. NBQX does not affect learning and memory tasks in mice: a comparison with d-CPPene and ifenprodil. Brain Res. Cogn. Brain Res. 1:1992;67-71.
33. Paylor R., Tracy R., Wehner J.M., Rudy J.W. DBA/2 and C57BL/6 mice differ in contextual fear but not auditory fear conditioning. Behav. Neurosci. 108:1994;810-817.
34. Paylor R., Baskall L., Wehner J.M. Behavioral dissociations between C57BL/6 and DBA/2 mice on learning and memory tasks: a hippocampal-dysfunction hypothesis. Psychobiology. 21:1993;11-26.
35. Phillips R.G., LeDoux J.E. Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav. Neurosci. 106:1992;274-285.
36. Phillips R.G., LeDoux J.E. Lesions of the dorsal hippocampal formation interfere with background but not foreground contextual fear conditioning. Learning Memory. 1:1994;34-44.
37. Pitsikas N., Algeri S. Effect of oxiracetam on scopolamine-induced amnesia in the rat in a spatial learning task. Pharmacol. Biochem. Behav. 43:1992;949-951.
38. Pontecorvo M.J., Evans H.L. Effects of aniracetam on delayed matching-to-sample performance of monkeys and pigeons. Pharmacol. Biochem. Behav. 22:1985;745-752.
39. Pugliese A.M., Corradetti R., Ballerini L., Pepeu G. Effect of the nootropic drug oxiracetam on field potentials of rat hippocampal slices. Eur. J. Pharmacol. 99:1990;189-193.
40. Rudy J.W. Contextual conditioning and auditory cue conditioning dissociate during development. Behav. Neurosci. 107:1993;887-891.
41. Satoh M., Ishihara K., Iwama T., Takagi H. Aniracetam augments, and midazolam inhibits, the long-term potentiation in guinea-pig hippocampal slices. Neurosci. Lett. 68:1986;216-220.
42. Satoh M., Ishihara K., Katsuki H. Different susceptibilities of long-term potentiations in CA3 and CA1 regions of guinea pig hippocampal slices to nootropic drugs. Neurosci. Lett. 93:1988;236-241.
43. Schopke R., Wolfer D.P., Lipp H.P., Leisinger-Trigona M.C. Swimming navigation and structural variations of the infrapyramidal mossy fibers in the hippocampus of the mouse. Hippocampus. 1:1991;315-328.
44. Singh L., Donald A.E., Foster A.C., Hutson P.H., Iversen L.L., Iversen S.D., Kemp J.A., Leeson P.D., Marshall G.R., Oles R.J., Priestley T., Thorn L., Tricklebank M.D. Enantiomers of HA-966 (3-amino-1-hydroxypyrrolid-2-one) exhibit distinct central nervous system effects: (+)-HA-966 is a selective glycine/N-methyl-D-aspartate receptor antagonist, but(-)-HA-966 is a potent γ-butyrolactone-like sedative. Proc. Natl. Acad. Sci. USA. 87:1990;347-351.
45. Smith S.E., Durmuller N., Meldrum B.S. The non-N-methyl-D-aspartate receptor antagonists, GYKI 52466 and NBQX, are anticonvulsant in two animal models of reflex epilepsy. Eur. J. Pharmacol. 201:1991;179-183.
46. Tan S.-E., Wenthold R.J., Soderling T.R. Phosphorylation of AMPA-type glutamate receptors by calcium/calmodulin-dependent protein kinase II and protein kinase C in cultured hippocampal neurons. J. Neurosci. 14:1994;1123-1129.
47. Tang C., Shi Q., Katchman A., Lynch G. Modulation of the time course of fast EPSCs and glutamate channel kinetics by aniracetam. Science. 254:1991;288-290.
48. Trickebank M.D., Singh L., Oles R.J., Preston C., Iversen S.D. The behavioral effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor. Eur. J. Pharmacol. 167:1989;127-135.
49. Trujillo K.A., Akil H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science. 251:1991;85-87.
50. Upchurch M., Wehner J.M. DBA/2Ibg mice are incapable of cholinergically-based learning in the Morris water task. Pharmacol. Biochem. Behav. 29:1988;325-330.
51. Upchurch M., Wehner J.M. Differences between inbred strains of mice in Morris water maze performance. Behav. Genet. 18:1988;55-68.
52. Upchurch M., Wehner J.M. Inheritance of spatial learning ability in inbred mice: a classical genetic analysis. Behav. Neurosci. 103:1989;1251-1258.
53. Vincent G., Verderese A., Gamzu E. The effects of aniracetam on the enhancement and protection of memory. Ann. NY Acad. Sci. 444:1985;489-491.
54. Wehner J.M., Sleight S., Upchurch M. Hippocampal protein kinase C activity is reduced in poor spatial learners. Brain Res. 523:1990;181-187.
55. Wang L.-Y., Dudek E.M., Browning M.D., MacDonald J.F. Modulation of AMPA/kainate receptors in cultured murine hippocampal neurones by protein kinase C. J. Physiol. 475:1994;431-437.
56. Wong E.H.F., Kemp J.A., Priestley T., Knight A.R., Woodruff G.N., Iversen L.L. The anticonvulsant MK-801 is a potent NMDA antagonist. Proc. Natl. Acad. Sci. USA. 83:1986;7104-7108.
57. Woodruff G.N., Foster A.C., Gill R., Kemp J.A., Wong E.H., Iversen L.L. The interaction between MK-801 and receptors for NMDA: functional consequences. Neuropharmacology. 26:1987;903-909.
58. Xiao P., Staubli U., Kessler M., Lynch G. Selective effects of aniracetam across receptor types and forms of synaptic facilitation in hippocampus. Hippocampus. 1:1991;373-380.